Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
NORTHVALE, N.J., March 17, 2011 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite") (OTCBB:ELTP) announces the settlement of a lawsuit filed in the Superior Court of New Jersey, Chancery...
-
NORTHVALE, N.J., March 4, 2011 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. (OTCBB:ELTP) advises that the US Food and Drug Administration (FDA) announced that it intends to remove approximately 500...
-
NORTHVALE, N.J., Feb. 14, 2011 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. (OTCBB:ELTP), a specialty pharmaceutical company dedicated to developing and commercializing oral controlled release...
-
NORTHVALE, N.J., Feb. 10, 2011 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. (OTCBB:ELTP), a specialty pharmaceutical company dedicated to developing and commercializing oral sustained and...
-
NORTHVALE, N.J., Feb. 8, 2011 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals Inc. ("Elite" or the "Company") (OTCBB:ELTP), a specialty pharmaceutical company dedicated to developing and commercializing...
-
NORTHVALE, N.J., Feb. 4, 2011 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCBB:ELTP) announced today the approval of an Abbreviated New Drug Application (ANDA) for...
-
NORTHVALE, N.J., Jan. 10, 2011 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCBB:ELTP) and Hi-Tech Pharmacal Co., Inc. ("Hi-Tech) (Nasdaq:HITK) today announced that...
-
NORTHVALE, N.J., Nov. 15, 2010 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. (OTCBB:ELTP), a specialty pharmaceutical company dedicated to developing and commercializing oral controlled release...
-
NORTHVALE, N.J., Nov. 9, 2010 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. (OTCBB:ELTP), a specialty pharmaceutical company dedicated to developing and commercializing oral sustained and controlled...
-
NORTHVALE, N.J., Sept. 16, 2010 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCBB:ELTP) announced today the signing of a license agreement and a manufacturing and...